American Society of Hematology articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/08/29 10:38
2014/08/29 10:38
3d
An experimental drug designed to help regulate the blood's iron supply shows promise as a viable first treatment for anaemia of inflammation. The present treatment strategy for anaemia of...
2014/08/29 10:38
2014/08/29 10:38
Latest videos
2014/08/25 22:22
2014/08/25 22:22
6d
NEW YORK (TheStreet) -- Kite Pharma (KITE) soared in after-hours trading on Monday after the company published successful data from its Phase 1-2a clinical trial of patients with aggressive...
2014/08/25 21:18
2014/08/25 21:18
6d
Shares of Kite Pharma are exploding higher in after-hours trading. The $827 million biotech firm just revealed positive outcomes from patients with aggressive non-Hodgkin's lymphoma after receiving...
2014/08/20 22:31
2014/08/20 22:31
11d
Blueprint for Next Generation of Chronic Myeloid Leukemia Treatment Available for logged-in reporters onlyCitationsCancer Cell Newswise — SALT LAKE CITY— Researchers at Huntsman Cancer Institute...
Read more at Newswise, Deseret News
2014/08/14 16:17
2014/08/14 16:17
18d
Forcing Chromosomes into Loops May Switch Off Sickle Cell Disease In a Novel Potential Therapy, CHOP Hematology Experts Manipulate Gene Regulation to Restore Healthy Hemoglobin in Red Blood...
2014/08/12 21:20
2014/08/12 21:20
19d
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined...
2014/08/06 10:17
2014/08/06 10:17
26d
SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based intratumoral cancer immunotherapy, has appointed Dr. Holbrook Kohrt, M.D., Ph.D., to the...
2014/08/04 17:08
2014/08/04 17:08
27d
Amgen (NASDAQ: AMGN) and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and...
2014/08/29 10:38
2014/08/29 10:38
Latest from Twitter